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Abstract
Gabrielle Chin
MINDFULNESS AND BLOOD PRESSURE ACROSS DEMOGRAPHICS:
ANALYSES FROM THE SERENITY STUDY
2018-2019
Jeffrey Greeson, Ph.D.
Master of Arts in Clinical Psychology
Mindfulness, as a state, trait, and training, is linked with myriad positive mental and
physical health outcomes. Understanding the individual characteristics potentially
influencing links between mindful traits, mindfulness training, and physical health, is
therefore important, yet remains under-addressed. Utilizing data from the ongoing
Serenity Study (NCT02371317), the current project examines if (1) at baseline, higher
trait mindfulness relates to lower BP consistently as a function of demographics, (2)
Mindfulness-Based Stress Reduction (MBSR) training lowers BP consistently across
demographic subgroups and initial levels of trait mindfulness, and (3) if change in trait
mindfulness following MBSR training correlates with change in BP following
mindfulness training, consistently across demographic groups. Results show that some
trait mindfulness facets relate differently to BP across race and gender, that MBSR
training may not be effective at lowering BP in demographics outside of people who are
White, that improvement in trait mindfulness may not drive change in BP after MBSR
training, and that mindfulness research would benefit from improved sample diversity to
explore potential demographic differences in the relationship between mindfulness and
health, rather than assuming beneficial effects generalize across populations.
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Chapter One

Introduction
An estimated 85.7 million adults, roughly 34% of Americans, are currently
diagnosed as having high blood pressure (BP), or hypertension (HTN): systolic blood
pressure (SBP) over 140 mmHg and/or diastolic blood pressure (DBP) over 90 mmHg
(Benjamin et al, 2017). HTN is the preeminent risk factor for cardiovascular disease
(CVD), causing 54% of stroke and 47% of ischemic heart disease events worldwide
(Lawes, Hoorn & Rodgers, 2008). In 2010, HTN was a component in 18% of all deaths
(9.4 million globally). The United States alone spends an estimated 46 billion dollars a
year treating this ubiquitous condition (Campbell et al, 2015). Typically, HTN treatment
includes antihypertensive medications, namely thiazide diuretics, beta blockers,
Angiotensin converting enzyme inhibitors (ACE inhibitors), Angiotensin II receptor
blockers (ARBs), and calcium channel blockers (CCBs; Chobanian, 2003), but most
commonly a combination of thiazide diuretics and ACE inhibitors (Jarari et al., 2015).
Both prevalence and severity of HTN differ across race.
Black people experience the highest rates of CVD incidence and CVD morbidity
compared with White and Hispanic people (Graham, 2015). An estimated 43.5% of nonHispanic Blacks, 33.0% of Hispanics, and 27.5% of non-Hispanic Whites fall within
adult diagnosable criteria for HTN established by the 7th Report of the JNC on
Prevention, Detection, Evaluation and Treatment of High Blood Pressure (Fei et al.,
2017). Other demographics have similar disparities-- older age is a primary risk factor for
HTN and CVD (North & Sinclair, 2012), men have higher lifetime CVD risk and
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morbidity than women (Mosca, Barrett-Connor & Wegner, 2011), and people with lower
SES have higher HTN and CVD incidence and morbidity compared against higher SES
people (Schultz et al., 2018).
In addition, effects of antihypertensive medications vary widely across
demographics, particularly race and degree of HTN. A single antihypertensive
medication is unlikely to effectively control BP for more than 25-50% of patients. For
example, ACE inhibitors are relatively ineffective at lowering BP in Black people (30%
response rate) but are more successful in White people (55% response rate; Sever, 1998).
Similarly, people with stage-one hypertension report better outcomes when prescribed
CCBs, ACE inhibitors or ARBs versus thiazide diuretics or beta-blockers (Gupta, 2010).
Most patients seen for HTN are diagnosed with elevated BP (SBP of 120-129 mmHg and
DBP of <80 mmHg) or stage one HTN (SBP of 130-139 mmHg or DBP of 80-89 mmHg;
Egan & Stevens-Farby, 2015).
Alarmingly, many people with milder forms of HTN are overtreated, and given
the same level of medication or the same medications as people with more severe BP
levels (Kerr et al., 2012). A recent review by the Cochrane Foundation highlighted this
discrepancy, analyzing drug treatment outcomes from 8,912 participants with pre-HTN.
Treatment with antihypertensive medications versus placebo did not reduce total
mortality, even after 4-5 years of medication. Furthermore, antihypertensive medications
did not reduce rates of coronary heart disease, stroke or total cardiovascular events in
79% of participants compared with a placebo. Adverse side-effects from
antihypertensives caused 9% of participants to cease treatment totally (Diao, Wright,
Cundiff & Gueyffier, 2012). Other studies have found specific and substantial adverse
2

effects of antihypertensive overmedication, including angioedema, kidney failure,
hastened cognitive decline, and atrophy in the thalamus, putamen and hippocampus as
well as decreased gray matter integrity (Gibbs, Lip & Beevers, 1999; Mossello et al.,
2015; Foster-Dingley et al., 2015; Foster-Dingley et al., 2015a). Although HTN is
controllable via lifestyle modifications paired with antihypertensive medication if
behavioral changes are ineffective (Egan & Farby, 2015), ultimately only one in five
people with HTN successfully manages their condition with conventional treatments,
often due to difficulty adhering to long-term lifestyle modifications and medication
regimens (Hamer, 2010). Given the prevalence, disparities, and suboptimal outcomes for
treating HTN, alternative approaches to managing high BP are necessary, specifically for
people with elevated BP but not full HTN.
Stress is another modifiable risk factor that is both an HTN source and an
instigator of other HTN risk factors, like poor diet and physical inactivity. Although
stress is largely environmentally driven, the perception of stress is a changeable internal
experience, thereby stress reduction may be a favorable treatment target. Stress impacts
BP via numerous biobehavioral mechanisms. Harmful chronic stress and cognitive
perseveration about stressors trigger biological stress reactions in the autonomic nervous
system and adrenocortical systems, cyclically inducing stress-related symptoms and
illnesses. Activation of these systems causes adrenal hormones like dopamine,
epinephrine and norepinephrine (catecholamines increasing cardiac output) to be
released, actuating acute stress responses maintaining short term homeostasis.
Paradoxically, effects of these stress-reactivity systems on the body are adverse when
activated too often, too strongly, or for extended lengths of time. Observed effects
3

include damaging the immune and sympathetic nervous systems, the hippocampalpituitary-adrenal axis, the vascular system, and hastening global pathology (McEwen,
2000). Allostatic load is this cumulative ‘wear and tear’ on bodily systems over time.
Normal, adaptive allostatic processes fail, and typical cardiovascular, neuroendocrine and
neuroenergetic responses become continuously active, leading to an inadaptability of
associated physiological systems. For example, inadaptability of the vascular system
increases arterial blood flow and repeatedly elevates BP, spurring development of
preclinical vascular pathology including endothelial cell damage and general vascular
overload, ultimately resulting in harmful vascular remodeling, in which arteries become
narrowed and hardened with plaque, lose elasticity, and this becomes vulnerable to HNT
(Peters, McEwen & Friston, 2017). The potency of chronic stress as a dually predictive
and developmental factor for many diseases, particularly HTN and CVD, conveys the
necessity of non-pharmaceutical, effective and accessible stress-reducing interventions
that positively impact physical health, while lessening disease risks and states. (Denollet,
Schiffer & Spek, 2010). Teaching people with high BP to better manage stress could help
control BP in at least two ways: (1) Directly buffering cardiovascular stress reactivity
thereby reducing allostatic load, and indirectly by (2) initiating and maintaining healthy
lifestyle changes typically compromised by chronic stress, like diet, exercise, and sleep.
An increasingly acknowledged potential intervention addressing this need is mindfulness.
Mindfulness
Mindfulness is commonly defined as nonjudgmental awareness of one’s presentmoment experience (Kabat-Zinn, 2009). Appearing in secular healthcare settings in the
United States 40 years ago, mindfulness practice is heralded as an innovative, non4

pharmacologic, and cost-effective method of stress reduction. One recent national survey
shows that 12% of Americans report using mindfulness techniques, like meditation, to
reduce stress (Herman et al., 2017; Kabat-Zinn, 1979; American Psychological
Association, 2017). The surging popularity of mindfulness is unsurprising, given the
considerable evidence of its effectiveness in reducing stress and bolstering well-being
(Greeson & Chin, 2019), and rising reports of stress and stress-related diseases across the
world (Regus, 2014).
Like stress, mindfulness can be conceptualized as a multidimensional concept. On
one hand, mindfulness is an inherent trait; everyone has some natural ability to be
mindful, and this ability varies across individuals. This is termed dispositional or trait
mindfulness. In addition, mindfulness can be a momentary state of balanced awareness
and acceptance, such as during meditation. Finally, mindfulness is also a training to
develop mindfulness skills through meditation practice such as through the eight-week
mindfulness based stress reduction (MBSR) training program (Shapiro & Carlson, 2009;
Lindsay, Young Smyth, Brown & Creswell, 2017). In theory, several different
mindfulness skills – sometimes called facets – are believed to reduce perceptions of stress
and self-regulate physiological responses that, over time, contribute to risk of HTN and
CVD (Greeson, 2009; Holzel et al., 2011; Shapiro, Carlson et al. 2005). For example, an
observant and present-moment oriented mindset may allow accurate appraisal of a
stressor, its context, and of subsequent cognitive, emotional, and bodily reactions.
Theoretically, this increased self-awareness, alongside decreased judgment and increased
acceptance of reactions to the stressor and related internal events, may reduce
physiological reactivity during stress. Cyclically, cultivation of this ‘mindful’ reappraisal
5

system in acute stress events (including adaptive changes in cognitions, emotions, and
physiological responses) could lead to long-term improvements in cognitions and
behaviors related to stress (Garland, 2017). A more mindful reappraisal system, formed
from high inherent levels of mindfulness as a trait or via mindfulness training, utilizing
core qualities of mindfulness like Observing (noticing details of internal and external
contexts), Describing (ability to put words to experiences), Nonjudging (accepting and
not evaluating experienced cognitions, emotions, and sensations), Nonreactivity
(allowing thoughts, feelings and sensations to pass without fixating or reacting to them),
and Acting with Awareness (ability to pay attention to current activities; not being on
‘autopilot’) could buffer acute biological stress reactivity, reduce allostatic load, and
thereby promote healthy BP in people at-risk for or with high BP (Creswell & Lindsay,
2014).
Preliminary explorations of the link between trait mindfulness and physical health
present mixed findings. A longitudinal study by Murphy, Mermelstein, Edwards and
Cidycz (2012) found that high trait mindfulness predicted good self-reported physical
health as measured by the Cohen-Hoberman Inventory of Physical Symptoms across a
10-week period. A cross-sectional epidemiologic study by Loucks et al. (2015) found that
participants with low levels of self-reported trait mindfulness as measured by the Mindful
Attention Awareness Scale who were not obese as children were more likely to become
obese in adulthood than participants with higher trait mindfulness scores. A later study by
Loucks et al. (2016) demonstrated that some elements of good vascular health, like low
fasting glucose, high physical activity, and not smoking, associated with high trait
mindfulness, while other elements such as BP, cholesterol level, and fruit or vegetable
6

consumption, were not. Tomfohr, Pung, Mills and Edwards (2015) investigated the
relationships between multiple subscales of trait mindfulness, BP, and interleukin-6 (IL6), resulting in varied findings, whereas higher scores on the Observing subscale of the
FFMQ correlated with lower levels of IL-6 when scores on the Nonreactivity subscale
were also high, with no other subscales showing associations. BP was not associated with
any subscales except among participants with high Nonjudging scores, such that as
Acting with Awareness increased, BP decreased. These initial results are inconclusive,
but indicate that different facets of trait mindfulness may relate differently to biological
markers of stress, including BP. Theoretically, improvements in trait mindfulness can
lead to increased mindful states and behaviors, thereby impacting health, so greater
understanding of how specific trait mindfulness facets change following mindfulness
training may inform possible causal mechanisms by which the training improves health
related outcomes (Carmody, Baer, Lykins & Olendzki, 2009). It is unknown if high
levels of trait mindfulness prior to mindfulness training improve health related outcomes
following mindfulness training, or conversely, if low levels of trait mindfulness allow for
more ‘room to grow’ during mindfulness training, thereby increasing benefit. Given the
relative paucity and inconsistency of data linking trait mindfulness and objective
biomarkers on cardiovascular health, further investigation of the links between trait
mindfulness, mindfulness training, and health in a diverse sample of adults with elevated
BP could inform more efficient utilization of mindfulness training as a complementary
intervention for stress-related physical conditions and diseases, like HTN and CVD.
While it is still unclear if trait mindfulness affects or relates to BP, early studies
indicate that mindfulness-based interventions (MBIs) may be a viable treatment for
7

stress-related physical conditions and diseases, given substantial evidence that MBIs
decrease subjective stress both short- and long-term (Martin-Asuero, 2010; Evans et al,
2011; Geary & Rosenthal, 2011; Britton, Shahar, Szepsenwol & Jacobs, 2012; BergenCico, Possemato & Cheon, 2013). One small randomized controlled trial (RCT)
compared MBSR training to progressive muscle relaxation (PMR) training in
unmedicated adults with pre-HTN and found that MBSR training significantly reduced
both clinic SBP (4.9 mmHg) and DBP (1.9 mmHg) versus PMR (Hughes et al., 2013).
Although changes in daytime and nighttime ambulatory SBP (3.5 mmHg) and DBP (1.4
mmHg) did not significantly differ from PMR, ambulatory SBP change in the MBSR
training group was clinically noteworthy (Hughes et al., 2013). BP changes of the size
found in this trial are known to reduce incidence of heart attack, stroke, and CVD-related
death, if sustained (Whelton et al., 2002). In contrast, a larger RCT with participants
diagnosed with stage 1 hypertension found that MBSR training had no effect on
ambulatory SBP (0.4 mmHg) and DBP (0.0 mmHg) compared against a waitlist control
group (Blom et al., 2014).
Studies of MBIs and BP reactivity to laboratory stressors generally support MBIs
as decreasing BP reactivity, but results are not wholly consistent. One RCT found that
MBSR training generated small decreases in BP reactivity to a mental arithmetic and
speech task (Nyklíček et al., 2013). A 3-armed RCT comparing app-based interventions
found that compared with other interventions, mindfulness intervention app reduced SBP
reactivity to the Trier Social Stress Test (Lindsay et al., 2018), while another RCT found
that brief mindfulness exercises lowered BP reactivity over the duration of a speeded
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math stressor (Steffen & Larson, 2015). Conversely, one RCT testing a brief mindfulness
exercise found no significant effects on BP reactivity to stress (Grant et al., 2013).
Initial research exists investigating the links between mindfulness, stress, and
cardiovascular health, is limited, and results are mixed. Yet, when considering
mindfulness as either a trait or interventional approach buffering and reducing high BP,
several critical issues in the current literature likely contribute to the apparent variation in
findings. The bulk of people utilizing MBIs are healthy, middle-age, high-income,
college-educated, female & White (Burke, Lam, Stussman & Yang, 2017). This specific
population also demographically mirrors most participants studied in mindfulness
research (Chin, Anyanso & Greeson, 2019). In contrast, the people most likely to be
diagnosed with HTN are older-age, lower SES, male, and non-White. Minimal research
has examined if mindfulness, as a trait or a training, influences physical health differently
across demographic characteristics like race, age, gender, and SES. This imbalance is
especially concerning when considering the substantial disparity of HTN alongside the
disparity in consequent negative CVD outcomes, across demographics (Fei et al. 2017;
Lackland, 2015). Initial research indicates that the effect of MBIs on BP is potentially
moderated by race. Palta et al.’s small pilot study evaluating MBSR training effectiveness
with older-adult Black participants (n = 12) produced highly significant results- more
than quadruple the reduction in SBP (21.92 mmHg) and over eight times the reduction in
DBP (16.7 mmHg) found in Hughes et al.’s largely White sample (Palta et al., 2012).
Greater understanding of potential variation in how mindfulness as a trait and training
affects people with demographically disparate, stress-related health conditions and
diseases like HTN is increasingly important given the rising popularity of MBIs as a
9

component of stress-related disease treatment. Still, diversity in mindfulness research
remains under-addressed.
Furthermore, much of the existing research on the relationship between
mindfulness and physical health utilizes subjective health measures versus objective
health measures. Mindfulness training impacts people’s interpretations of and reactions to
physical illness and pain, generating improvement on subjective health measures.
Although these changes may reflect improved well-being and quality of life, subjective
health improvement does not parallel recovery or improvement in objective health
measures related to physical disease, like BP (Greeson & Chin, 2019). Additionally,
studies utilizing objective measures only sporadically collect data on relevant covariates.
Extensive past research has identified covariates of BP, yet few mindfulness trials have
controlled for these factors when analyzing BP, even if data on these covariates are
collected as part of the trial. Common alternatives include controlling for pre-training BP
levels (Hughes et al., 2013; Lindsay et al., 2018), or only collecting and utilizing
information on some of the known relevant covariates, often age, sex, BMI or
antihypertensive use (Nyklíček et al., 2013; Palta et al., 2013). Methodological
improvements, like increased use of objective health measures alongside controlling for
all possible relevant covariates, may clarify how mindfulness relates to physical health.
Therefore, the current study used both cross-sectional and longitudinal data from
an ongoing multisite clinical trial to address methodological limitations common in the
current field of mindfulness and cardiovascular health. Based on a review of the
literature, and informed by pertinent theories, we propose three research questions: (1) At
baseline, does higher trait mindfulness relate to lower BP after controlling for known
10

covariates of BP, and does this relationship differ as a function of demographics? (2)
Does MBSR training lower BP, and does it do so across demographic subgroups and
initial levels of trait mindfulness? (3) Finally, is change in trait mindfulness correlated
with change in BP following MBSR training, and does this association occur across
demographic subgroups?
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Chapter Two

Methods
The current study proposed to analyze both baseline and pre-post intervention
data from the Serenity Study (NCT02371317), an ongoing multi-site RCT comparing the
efficacy of MBSR training and stress-management education (SME) in lowering BP
among adults with pre-HTN.
Participants

Table 1
Sample Demographics
All
296
N
25%
Race (% Black)
69%
Race (% White)
50.7
Age
58%
Gender (% Female)
SES (% Lower) 47.7%
28.7
BMI
Smoking History (% Smoked) 22.4%
1.4%
Risky Drinking (% Engage)
Healthy Diet (% Healthy) 40.1%
2.5
Hours Exercised/Day
6.9
Hours Slept/Day
123.7
Clinic SBP (mmHg)
72.9
Clinic DP (mmHg)
Ambulatory SBP (mmHg)
Ambulatory DBP (mmHg)
SBP Reactivity (mmHg)
DBP Reactivity (mmHg)
Observing 26.49
Describing 28.03
Acting with Awareness 26.71
Nonjudging 28.08
Nonreactivity 21.04
Decentering 42.02

RCT
156
28.1%
69.4%
49.7
52%
52.5%
29.3
22.2%
2.5%
37.7%
2.6
6.9
124.4
73.5
142.9
84.5
10.9
9.1
26.64
28.10
27.09
28.13
21.03
42.23
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OL
140
20.6%
68.8%
51.7
65.2%
41.9%
28
22.7%
0%
43%
2.4
6.8
122.8
72.1

26.28
27.95
26.31
27.97
20.98
41.73

Baseline. Participants (N = 296; Mage = 50.69, SD = 12.77) include medicated and
unmedicated men (42.1%) and women (57.9%) with and without pre-HTN (SBP of 120-139 or DBP of 80--89, consistent across two clinic assessments) as measured by criteria
established by the 7th Report of the Joint National Committee (JNC) on Prevention,
Detection, Evaluation and Treatment of High Blood Pressure. Regarding race, 206
(69.1%) identified as White, 74 (24.8%) as Black, 19 (6.4%) as Asian, 6 as Native
American/Alaskan (2%), and 1 as Pacific Islander (.3%). People were excluded from the
RCT if they were morbidly obese (BMI = 40), if they had existing heart disease as
evidenced by a pacemaker, atrial fibrillation, myocardial infarction, percutaneous
transluminal coronary angioplasty, coronary artery bypass graft within six months of
enrollment, persistent tachyarrhythmia, congestive heart failure, uncorrected primary
valvular disease, hypertrophic or restrictive cardiomyopathy, or uncorrected thyroid
disease, chronic kidney disease, or if they fell within JNC risk category C (including
target organ damage and diabetes). In addition, people were excluded if they were
pregnant or planning to become pregnant within nine months, lactating, unable to comply
with assessment procedures, unable to provide informed consent, or had dementia; and if
they had abused alcohol or drugs in previous 12 months, regularly consumed more than
21 alcoholic drinks per week, been current smokers, or if they already had 27 hours of
formal, or 56 hours of informal, meditation or yoga training. Baseline data included RCT
participants as well as open-label participants. Open-label (OL) participants were
excluded from the formal RCT due to not meeting eligibility criteria, but they still opted
to take part in the MBSR training or SME interventions in exchange for providing BP
and other relevant data. Open-label participants were mainly included to form viable
13

MBSR training and SME group sizes. Moreover, the larger combined sample size
improved statistical power for baseline analyses. And, many of the open-label
participants still had relatively high BP and qualified as prehypertensive, given the
recently lowered criteria in American Heart Association high BP guidelines (Whelton et
al., 2017). See Table 1 for further participant demographic information.
Pre-post intervention. RCT participants in the MBSR training group (N = 44;
Mage = 49, SD = 13.1) included unmedicated men (48.9%) and women (51.1%) with
elevated BP, consistent across two clinic assessments) as measured by criteria established
by the 7th Report of the JNC on Prevention, Detection, Evaluation and Treatment of High
Blood Pressure. Among these participants, 31 (68.9%) identified as White, 11 (24.4%) as
Black, 2 (4.4%) as Asian/Pacific Islander, and 1 as mixed-race (2.2%). People were
excluded identically to baseline exclusion criteria. See Table 1 for further participant
demographic information.
Procedure
The institutional review boards of Kent State University and University of
Pennsylvania reviewed and approved study procedures. All potential participants
completed initial eligibility and medical screening over the phone by study staff, or
online via REDCap. Potential participants not excluded after the initial screening were
then scheduled for the first in-clinic screening session, where clinic BP was determined,
following standard American Heart Association (AHA) procedures (Pickering et al.,
2005). Potential participants were asked to refrain from vigorous exercise and consuming
alcohol and caffeine for at least four hours before their appointment time.
14

Potential participants with three consistent (within 5 mmHg) pre-hypertensive BP
readings during the initial BP screening visit were further considered as eligible. One
week later, a second, confirmatory clinic screening of BP determined final eligibility by
repeating the BP assessment. Participants were then consented and enrolled, and
additional baseline assessments of demographic information and self-report measures,
including stress and mindfulness, were completed.
As illustrated in Figure 1, enrolled RCT participants were randomly assigned to
one of three conditions: (1) MBSR training, (2) a Stress Management Education (SME)
active control group, or (3) a wait-list control (AHA Recommended Self-care). Five total
study visits occurred following enrollment: (1) pre- class visit, (2) mid -point visit, (3)
post- class visit, (4) at 6-month follow up, and (5) 12-month follow up. Participants
randomized to the wait-list (AHA self-care) group also completed pre-, mid- and postvisits over the 8-week intervention period. Clinic BP was measured, and questionnaires
were completed at all study visits. Participants randomized to the MBSR training or SME
groups completed mental stress testing and ambulatory BP monitoring at the pre-class,
post-class, and 12-month follow up visits. Participants randomized to the AHARecommended Self-care group completed mental stress testing and ambulatory BP
monitoring at pre-self-care, post-self-care phase, and at the 12--month follow up visit
after taking part in their stress management program of choice. Clinic BP, ambulatory BP
procedures and mental stress testing/BP reactivity are described in the measures section
below. OL participants (who were not enrolled in the RCT) did not take part in
ambulatory BP or mental stress testing lab visits.
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Figure 1. Enrolled participants were randomly assigned to one of three conditions,
including MBSR training, an SME active control group, or AHA Recommended Selfcare, a wait-list control.
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Measures
Clinic BP. Clinic BP, the ‘gold standard’ measure of BP and the primary trial
endpoint, was measured via an automatic oscillometric monitor, the Datascope Accutorr
Plus™ (Mawah, NJ, USA). All clinic BP assessments were completed in a quiet and
climate-controlled room, following AHA guidelines (Pickering, 2005). Participants had
their BP reading taken from their non-dominant arm (supported at heart level) while
seated in a chair with feet flat on the floor. The mean of three consistent seated readings
of BP on the non-dominant arm was calculated to find clinic BP. If these three readings
varied by more than 5 mmHg for SBP or DBP, further readings were taken at five-minute
intervals, until either three consecutive readings ranging within 5 mmHg were collected,
or until a maximum of six measures were taken. Potential participants whose SBP or
DBP varied by more than 5 mmHg after six readings were considered ineligible due to
excessive variability in BP.
Ambulatory BP. Ambulatory BP was measured via an automatic oscillometric
monitor, the Oscar 2™ (SunTech Medical, Morrisville, NC). Participants were asked to
wear the monitor for 24 hours following their pre-class visit, and to keep the monitor on
while sleeping. The monitor collected BP readings every 20 minutes during the day (6
AM to 11 PM; 51 measures) then every 30 minutes during the night (11 PM to 6 AM; 14
measures). During each reading, participants were instructed to drop their arms to their
sides as soon as they sense the cuff inflating, and to keep it relaxed and still until a few
seconds after the deflation has finished.
BP reactivity. BP reactivity to stress was measured via an automatic
oscillometric monitor, the Datascope Accutorr Plus™ (Mawah, NJ, USA). BP reactivity
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was calculated as a change score, by subtracting mean BP scores during the baseline rest
period from mean BP scores during the anger recall task (ART), a brief (5-min)
emotional stressor in which subjects were instructed to first recall, visualize and then
verbally describe “a time that made you angry and when you think about it today, still
makes you angry.” (Greeson et al., 2009). The ART has been shown to reliably increase
BP and HR (Schwartz et al., 2000).
Demographics and self-report questionnaires. Assessments included collection
of demographic information, such as age, gender, race and SES/household income, as
well as a battery of widely-used self-report measures of stress-related psychological
symptoms and health behaviors. Self-report measures included the DASH diet diary
(Appendix A), the Stanford 7-Day Physical Activity Recall Scale (Appendix B), and an
assessment of health behaviors including smoking and alcohol intake, among others.
Trait mindfulness. Trait mindfulness was assessed via two scales. The first
measure, the Five Facet Mindfulness Questionnaire (FFMQ; Appendix C), is a widely
utilized 39-item gauge of trait mindfulness with questions distributed amongst five core
facets including: Observing (8 items; α = .810), Describing (8 items; α = .874), NonJudgment (8 items; α = .934), Non-Reactivity (7 items; α = .881), and Acting with
Awareness (8 items; α = .902). Questions on the FFMQ lie on a five-point Likert scale,
ranging from one (never or very rarely true) to five (very often or always true). The
FFMQ can be scored as a single total or by subscales, examining each facet individually
(Gu et al., 2016). The second measure was the Decentering subscale of the Experiences
Questionnaire (EQ; Appendix D), an 11-question self-report measure of another core
feature of mindfulness- Decentering, or viewing experiences and perceptions objectively
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without over-identifying with them (α = .792). Higher scores on the FFMQ and the
Decentering subscale of the EQ indicate higher trait mindfulness (Baer, Smith, Hopkins,
Krietemeyer & Toney, 2006; Fresco et al., 2007). Both measures have adequate construct
validity in adult samples (Goldberg et al., 2016; Fresco et al., 2007).
Interventions
Intervention descriptions were adapted from the Serenity Study grant application
(NCT02371317).
Lifestyle modification. All eligible study participants received lifestyle
modification advice consistent with JNC-7 recommendations for prehypertension, via an
American Heart Association brochure (titled “Understanding and Controlling Your High
Blood Pressure”) handed out to participants and briefly reviewed by a study staff
member (American Heart Association, 2003). Specifically, patients were advised to lose
weight if they were overweight, eat a healthy diet high in fruits and vegetables and low in
saturated fat, cholesterol and salt, increase physical activity, and limit alcohol to no more
than one drink each day for women and no more than two drinks a day for men.
Mindfulness based stress reduction (MBSR). The traditional MBSR training
was based on the current curriculum developed by Drs. Saki Santorelli and Jon KabatZinn (Santorelli & Kabat-Zinn, 2009). MBSR instructors (trained by Drs. Kabat-Zinn and
Santorelli) followed the standard 8-week program, session-by-session. The MBSR
program includes eight 2.5-hour weekly group sessions, in which participants were
instructed in three core mindfulness meditation exercises: sitting meditation, body scan,
and gentle mindful yoga. All meditation practices were designed to cultivate a decentered
perspective, by paying attention to one’s present-moment experience in a non-judging,
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non-reactive, allowing way. For example, in all mindfulness exercises, participants focus
their attention on the target of observation and remain aware of it in each moment. When
thoughts, emotions, or sensations arise, they were observed nonjudgmentally, without
having to change anything. With practice, MBSR training participants come to see that
most sensations, thoughts, and emotions are transient and do not require a deliberate
attempt to suppress them or change them. Outside of the weekly class sessions, MBSR
training participants were expected to practice formal mindfulness meditation exercises at
home at least 45 minutes per day, six days per week. They were also encouraged bring
mindfulness to everyday activities (e.g., eating, walking, driving, communicating with
others). In Week 6, the class met for a Day of Mindfulness silent retreat, guided by the
MBSR instructor. The full-day (9am-4pm) retreat provided a unique opportunity to
practice being mindful continuously, as a community devoted to living more mindfully.
MBSR instructors encouraged class participants to apply what they learn through
practicing mindfulness to their everyday life and behavior, with the common goal of
lowering BP by better controlling reactions acute stress and making conscious decisions
to maintain healthy lifestyle behaviors in the face of chronic stress. MBSR training
participants were also invited to attend subsequent Days of Mindfulness during the study.
Finally, to maximize relevance and engagement for study patients with prehypertension,
didactic material on emotions, stress physiology, coping, communication styles, and
everyday examples of mindless “autopilot” behavior, such as overeating, overworking,
having too much “screen time”, avoiding exercise, and cutting back on sleep, were
presented in the context of high BP.
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Stress management education (SME). SME is an 8-week, group-based
psychoeducational program designed to serve as an active control intervention for MBSR
training (Hodge et al., 2013). SME is intended to provide equipoise for the non-specific
elements of MBSR training without any of the putative active ingredients (e.g.,
mindfulness, yoga, etc.). Like MBSR training, SME patients learn about how stress
affects health, participate in a supportive social environment, receive attention from a
course instructor, hold a positive expectancy for healthy change, and engage in light
physical exercise. SME also has the same in-class and home exercise time as the MBSR
program, including a “Day of Stress Management” in the 6th week of SME, paralleling
the “Day of Mindfulness” meditation retreat in MBSR training. SME also matches
MBSR training for core elements of didactic content on how stress relates to eating
patterns and nutrition, exercise, sleep, and time management. Time devoted to in-session
educational activities and group discussion is also matched.
Wait-list control (WLC). Pre-hypertensive patients randomly assigned to the
WLC condition engaged in BP and laboratory stress assessments concomitant with
patients in the MBSR training or SME arms. After the post-intervention assessment,
WLC participants were invited to participate in their choice of MBSR training or SME,
based on their personal preference. Mid-treatment, post-intervention, and 6- and 12month follow-up assessments were then conducted for WLC participants during their
active interventions.
Data Analyses
Outcome measures included clinic SBP and DBP, ambulatory SBP and DBP, as
well as SBP and DBP reactivity to stress. Clinic BP was calculated by averaging three BP
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readings following standard AHA protocol (Pickering et al., 2005). Ambulatory BP was
calculated by averaging all valid readings obtained during daytime and nighttime, to
compute separate daytime and nighttime means (Hughes, 2013). BP reactivity to stress
was calculated by subtracting a participant’s mean BP score (derived across five BP
readings) during the baseline rest period from their mean BP score (derived across five
BP readings) during the anger recall task. Descriptive statistics were performed via SPSS
23 software. The variables of interest and their residuals were screened for violations of
relevant statistical assumptions, as well as outliers and missing data, prior to formal
analyses. Missing data were imputed via multiple imputation in both SPSS 23 and R.
Internal consistency of measures utilized were examined via Cronbach’s alphas. To
correct for multiple comparisons, a familywise alpha adjustment was applied to the alpha
level for traditional statistical significance tests (p = .05 divided by a family of six
primary outcome measures [clinic SBP and DBP; ambulatory SBP and DBP; reactivity
SBP and DBP], resulting in α=.008; Holland & Copenhaver, 1987).
Aim 1 data analyses. At baseline, does higher trait mindfulness relate to lower
BP after controlling for known covariates of BP, and does this relationship differ as a
function of demographics (race, age, gender and SES)? We predict that higher trait
mindfulness relates to lower BP, and that this relationship remains consistent across
demographics, as trait mindfulness emphasizes skills that are theoretically inherently
accessible to all people. To answer this research question, we used baseline data (n=296)
from the ongoing RCT, the Serenity Study (NCT02371317), including participants in the
RCT and OL groups (n=296). First, we tested if higher trait mindfulness related to lower
BP after controlling for known covariates of BP via hierarchical multiple regression. The
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first step of the model included known covariates of BP collected during the trial,
including BMI, smoking history, risky alcohol use, healthy diet, hours exercised weekly,
and hours slept daily, as well as dummy-coded demographic characteristics with known
CVD and BP disparities-- race, age, gender and SES. The second step of the model had a
trait mindfulness variable (Observing, Describing, Acting with Awareness, Nonjudging,
Nonreactivity, or Describing). All continuous predictor variables were centered. This
model was repeated across SBP and DBP in clinic BP, ambulatory BP, and BP reactivity,
for each trait mindfulness facet, for a total of 36 models, each showing how a trait
mindfulness facet predicted a form of BP. However, the ambulatory BP and BP reactivity
analyses included fewer BP covariates due to smaller sample size and less statistical
power. BP covariates used for these analyses included BMI, alongside the demographic
categories linked with BP (see Tables 2-3). These relationships were interpreted via
unstandardized regression coefficients (B) and associated p-values.
To answer if the relationship between trait mindfulness and BP differs as a
function of demographics, we ran moderation analyses predicting the different forms of
BP (clinic BP, ambulatory BP, BP reactivity) within the same sample. Model
comparisons between a full model, including covariates of BP and demographic
characteristics linked with BP, a single trait mindfulness variable (for example,
Observing), and interaction terms between that trait mindfulness variable and
demographic characteristics (for example, including the interaction terms between
Observing and Race, Observing and Gender, Observing and Age, Observing and SES,
etc.) and a reduced model, which dropped the trait mindfulness/demographic interaction
terms, elucidated if the relationship between individual trait mindfulness facets and BP
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differed as a function of demographics. R2 difference significance was measured via pvalues, and model selection validity was evaluated via BIC and BF. If the R2 difference
between the full and reduced models reached alpha adjusted significance, it was
interpreted as the relationship between that specific trait mindfulness facet and BP
differing as a function of demographics, as the interactions would explain an increased
proportion of variance in BP compared against the reduced model without interactions.
BIC and BF were included as metrics to identify occurrence of model overfitting
potentially causing the appearance of demographic differences in the relationship
between trait mindfulness facets and BP with even small increases in variance explained
(Kass & Raftery, 1995). The R package ‘dustinfife/fifer’, and function
‘impute.model.comparison’, were used to complete the multiple imputation and model
comparisons, including R2 p-value, Bayesian Information Criterion (BIC) and Bayes
Factor (BF) as metrics, using the imputed data.
Power analyses were completed with G*Power 3.1 software. For a multiple
regression assuming an alpha level of .05 and power of .95, the necessary sample size
was 292 participants. The final sample size used in the clinic BP analyses was 296
participants, including RCT and OL participants. However, the final sample for
ambulatory BP and BP reactivity to stress were underpowered to detect smaller effects,
with sample sizes of 94 and 152, respectively, including only RCT participants.
Aim 2 data analyses. Does MBSR training lower BP, and does it do so across
subgroups and initial levels of trait mindfulness? Due to low sample size (n=44), we
treated this aim as a ‘pilot’ analysis, using pre-post data from the Serenity Study
(NCT02371317). Specifically, we included RCT participants randomized to the MBSR
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training group across sites, and calculated the clinic BP pre-post mean difference in the
whole sample and within each subgroup. Effect size (ES) calculated using Hedges’ G for
paired samples was the primary metric of choice, as Hedges’ G natively corrects for
errors generated by small sample sizes (Borenstein, Hedges, Higgins & Rothstein, 2011).
One prior meta-analysis of 8,500 participants with high BP found that an ES of .235
equaled a SBP change of 3 mmHg (Conn, Ruppar & Chase, 2016). A small negative (.235) ES of MBSR training on BP was therefore understood as potentially clinically
relevant, if the confidence intervals (CIs) did not contain zero (Hagins, States, Selfe &
Innes, 2013; Appel et al., 2006). Although the predicted changes were modest, they are
similar in scale to other health behavior modifying therapies for high blood pressure, and
are considered clinically relevant for people with prehypertension (Whelton et al., 2002).
Differences in intervention ES between demographic subgroups were compared by
calculating 95% CIs for each subgroup ES. If the 1) the CIs of the relevant ES did not
contain zero, and 2) the CIs had at or under a quarter of overlap across demographic
subgroups, the CI differences were interpreted as significant between the two ESs (Belia,
Fidler, Williams & Cumming, 2005; McGough & Faraone, 2009).
Aim 3 data analyses. Finally, are changes in trait mindfulness facets and BP
following MBSR training correlated, and do these correlations occur across different
subgroups (age, gender, race, SES) and different initial levels of trait mindfulness? Due
to low sample size, we treated this as a ‘pilot’ analysis, and using pre-post data from the
Serenity Study (NCT02371317), calculated correlations between change in trait
mindfulness facets after MBSR training and change in mean clinic BP after MBSR
training for each subgroup. Correlation coefficient ES was the primary metric of choice,
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and moderate (-.3) ESs with CIs not containing zero were understood as a potentially
meaningful link between changes in specific trait mindfulness facets and changes in BP
following MBSR training. Again, differences in correlation coefficient ES between
demographic subgroups were compared by calculating 95% CIs for each subgroup ES. If
the 1) the Cis of the relevant ES did not contain zero, and 2) the CIs had at or under a
quarter of overlap across demographic subgroups, the CI differences were interpreted as
significant between the two ESs.

26

Chapter Three

Results
Results
Aim 1. At baseline, does higher trait mindfulness relate to lower BP after
controlling for known covariates of BP, and does this relationship differ as a function of
demographics (race, age, gender and SES)?
Separate regressions were conducted for SBP and DBP for each type of BP
(Clinic BP, ambulatory BP, and BP reactivity to stress), predicting SBP or DBP from one
of six facets of trait mindfulness at a time in separate regression models: Observing,
Describing, Acting with Awareness, Nonjudging, Nonreactivity, and Decentering. Within
clinic BP, ambulatory BP, and BP reactivity to stress, after controlling for covariates of
BP, no mindfulness facets significantly related to BP, overall indicating a null
relationship between BP and trait mindfulness.
Model comparisons showed that the relationship between trait mindfulness and
BP did appear to differ as a function of demographics in some but not all facets. Within
clinic BP, the reduced models accounted for relatively small amounts of variance in BP.
However, the full models, with interaction terms added to account for potential
demographic differences, showed small but significant increases in variance explained
for SBP for Observing and Nonjudging, and for DBP for Acting with Awareness and
Nonjudging, based on R2 difference p-values, as shown in Table 2. Yet, when taken
together with the BIC and BF favoring the reduced models—an indication that they may
be more efficient— a plausible interpretation is that overfitting may have generated the
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appearance of demographic differences in the relationship between trait mindfulness
facets and clinic BP.

Table 2
Results of the Clinic BP Model Comparisons For Each Trait Mindfulness Facet (n=296)
Model

R2

Full
Reduced
Full
Reduced
Full
Reduced
Full
Reduced
Full
Reduced
Full
Reduced

BIC

BF

P

R2

BIC

BF

P

DV=SBP; Observing Facet
0.097 -31345.060
6.95E+26 <.001
0.088 -31468.670
DV=SBP; Describing Facet
0.093 -31526.030
1.23E-107 1.000
0.092 -31033.700
DV=SBP; Acting with Awareness Facet
0.091 -31578.050
4.96E+38 0.119
0.085 -31756.250
DV=SBP; Nonjudging Facet
0.116 -30279.430 3.63E+151 <.001
0.107 -30977.390

DV=DBP; Observing Facet
0.035 -17385.400 3.63E+26 0.986
0.035 -17507.710
DV=DBP; Describing Facet
0.045 -17173.450 9.59E+48 0.070
0.040 -17399.020
DV=DBP; Acting with Awareness Facet
0.055 -17044.740 1.99E+98 <.001
0.036 -17497.420
DV=DBP; Nonjudging Facet
0.059 -17053.210 1.02E+29 <.001
0.047 -17186.790

DV=SBP; Nonreactivity Facet

DV=DBP; Nonreactivity Facet

0.082
0.080

-31721.550
-31748.270

634281.6

0.089
0.081

DV=SBP; Decentering
-31330.290
2.36E+37
-31502.390

0.660

0.087

0.035
0.035

-17493.790
-17363.000

3.98E-29

1.000

0.042
0.033

DV=DBP; Decentering
-17551.810 5.62E-10
-17509.210

0.019

Within Ambulatory BP, the reduced models again accounted for small amounts of
variance in BP. In comparison, the full models showed small but significant increases in
variance explained for both SBP and DBP in Observing, Describing, Acting with
Awareness and Nonjudging, and for just DBP in Decentering, as shown in Table 3.
Again, when considering the metrics altogether, it is plausible that the appearance of
demographic differences in the relationship between trait mindfulness facets and clinic
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BP based on R2 difference p-values resulted from overfitting, as the BIC and BF metrics
favored the reduced models.

Table 3
Results of the Ambulatory BP Model Comparisons For Each Trait Mindfulness Facet (n=96)
Model

R2

BIC

BF

P

R2

BIC

DV=SBP; Observing Facet
Full
Reduced

0.065
0.036

-11386.800
-11698.000

3.75E+67

BF

P

DV=DBP; Observing Facet
<.001

0.145
0.097

-7196.167
-7559.605

8.31E+78

<.001

DV=SBP; Describing Facet

DV=DBP; Describing Facet

Full
Reduced

0.107 -10089.610 1.00E+210 <.001
0.035 -11056.710
DV=SBP; Acting with Awareness Facet

0.158 -7193.794 5.20E+142 <.001
0.084 -7851.026
DV=DBP; Acting with Awareness Facet

Full
Reduced

0.066
0.037

0.145
0.108

-10955.560
-11241.160

1.04E+62

<.001

DV=SBP; Nonjudging Facet
Full
Reduced

0.152
0.034

-10108.610
-11202.280

3.08E+237

0.053
0.052

-10818.520
-11251.180

8.93E+93

<.001

0.159
0.089

0.052
0.044

-11021.470
-11524.870

2.05E+109

<.001

-7079.928
-8048.475

2.08E+210

<.001

DV=DBP; Nonreactivity Facet
1.000

0.098
0.096

DV=SBP; Decentering
Full
Reduced

3.05E+123

DV=DBP; Nonjudging Facet

DV=SBP; Nonreactivity Facet
Full
Reduced

-7345.234
-7913.900

-7812.671
-7963.044

4.50E+32

1.000

DV=DBP; Decentering
0.061

0.146
0.100

-7204.571
-7791.575

2.93E+127

<.001

Within BP reactivity, the reduced models similarly accounted for a small amount
of variance in BP reactivity to stress. In comparison, the full models accounting for
demographic differences again showed small but significant increases in variance
explained for SBP and DBP for Acting with Awareness and Nonjudging, for just SBP in
Nonreactivity and Decentering, and for just DBP in Observing and Describing, as shown
in Table 4. Still, with all metrics taken together, as the BIC and BF favored the reduced
models, it is plausible that the appearance of demographic differences in the relationship
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between trait mindfulness facets and BP reactivity based on R2 difference p-values
resulted from overfitting.

Table 4
Results of the BP Reactivity Model Comparisons For Each Trait Mindfulness Facet (n=152)
Model

R2

Full
Reduced
Full
Reduced
Full
Reduced
Full
Reduced

BIC

BF

P

R2

BIC

BF

P

DV=SBP; Observing Facet
0.066 -11537.530 1650.897 0.983
0.063 -11552.350
DV=SBP; Describing Facet
0.075 -11586.120 2.66E-20 0.014
0.061 -11495.970
DV=SBP; Acting with Awareness Facet
0.129 -10970.900 3.92E+73 <.001
0.079 -11309.810
DV=SBP; Nonjudging Facet
0.124 -11007.930 1.33E+28 <.001
0.093 -11137.450

DV=DBP; Observing Facet
0.040 -5294.515
1.99E+45 <.001
0.016 -5503.121
DV=DBP; Describing Facet
0.040 -5406.505
5.42E+21 <.001
0.015 -5506.594
DV=DBP; Acting with Awareness Facet
0.055 -5213.006
5.50E+52 <.001
0.014 -5455.886
DV=DBP; Nonjudging Facet
0.142 -4627.348 1.41E+119 <.001
0.060 -5176.047

DV=SBP; Nonreactivity Facet

DV=DBP; Nonreactivity Facet

Full
Reduced

0.088
0.076

Full
Reduced

0.098
0.079

-11162.860 1.55E+64
-11458.460
DV=SBP; Decentering
-11232.620 1.64E+15
-11302.690

<.001

0.022
0.017

<.001

0.026
0.018

-5369.602
6.20E+28
-5502.195
DV=DBP; Decentering
-5407.251
5.88E+16
-5484.477

0.162
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In summary, although trait mindfulness and BP do not seem to relate before
accounting for potential demographic differences, a small but significantly increased
amount of variance in BP was explained by some trait mindfulness facets when the
interactions between trait mindfulness and demographic variables were added as the third
step of the model. Still, as shown in Tables 2-4 the BIC and BF metrics overwhelmingly
favored the reduced models, indicating that although accounting for potential
demographic differences generated small improvements to model fit, said improvements
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may result from model overfitting inflating the R2 metric (Kass & Raftery, 1995). These
results imply that the relationship between some trait mindfulness facets and BP may
differ slightly but significantly across demographic groups. However, 1) due to the
number of predictors and the BIC and BF favoring the reduced models, it was unclear if
overfitting generated these results, and 2) it was indeterminable if specific demographics
were driving these possible moderating effects as all four demographic interactions being
included simultaneously.
Aim 1 exploratory analyses. Therefore, to determine if specific demographics
drove observed significant differences within the model comparisons described as the
main results of Aim 1, we tested a single demographic at a time. To do so, we utilized
exploratory model comparisons between full models, in this case including covariates of
BP, the relevant trait mindfulness variable and a single interaction term between that trait
mindfulness variable and one demographic at a time, and reduced models, excluding the
interaction term. Within each trait mindfulness facet that was previously found to vary in
its relationship with BP as a function of demographics, the alpha adjusted p-values
(α=.008) were used to determine if the full model accounted for significantly more
variance than the reduced. BIC and BF were again utilized to identify occurrence of
model overfitting causing the appearance of demographic differences in the relationship
between trait mindfulness facets and BP with even small increases in variance explained
(Kass & Raftery, 1995). If a full model with a single demographic both reached statistical
significance via R2 difference p-value, and was favored by the BIC and BF compared
against a reduced model, it was interpreted as responsible for the earlier observed
demographic differences in the relationship between that trait mindfulness facet and BP.
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Table 5
Results of the Clinic BP Model Comparisons For Observing (n=296)
Model

R2

BIC

BF

P

R2

BIC

BF

P

DV=SBP; Race
DV=DBP; Race
Full
0.094 -30787.660 3.67E+163 <.001 0.035 -17457.420
6.64E+12
1.000
Reduced 0.085 -31540.900
0.035 -17516.470
DV=SBP; Age
DV=DBP; Age
Full
0.091 -31417.460
8.46E+02
1.000 0.035 -17592.730
5.50E-18
0.047
Reduced 0.089 -31430.940
0.035 -17513.250
DV=SBP; Gender
DV=DBP; Gender
Full
0.086 -31877.910
4.85E-82
0.477 0.034 -17436.450
1.33E+31
1.000
Reduced 0.087 -31503.450
0.034 -17579.780
DV=SBP; SES
DV=DBP; SES
Full
0.091 -31269.340
8.20E-44
0.016 0.037 -17480.710 62563383947 0.300
Reduced 0.089 -31070.920
0.034 -17530.430
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

In clinic BP, the relationship between the Observing facet and SBP seemed to
vary significantly as a function of race based on the R2 difference p-values though the
BIC and BF favored the reduced model as more efficient, shown in Table 5. The
relationship between Observing and DBP did not appear to differ across demographics.
The relationship between Describing and BP did not differ across demographics.
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Table 6
Results of the Clinic BP Model Comparisons For Acting with Awareness (n=296)
BIC
BF
P
R2
BIC
BF
P
DV=SBP; Race
DV=DBP; Race
Full
0.085 -31455.210 2.54E+40 0.039 0.038 -17445.580
7.97E-08
1.000
Reduced 0.083 -31641.280
0.037 -17412.890
DV=SBP; Age
DV=DBP; Age
Full
0.085 -31747.870 3.25E-32 1.000 0.045 -17367.720
1.04E+26
0.004
Reduced 0.086 -31602.860
0.036 -17487.530
DV=SBP; Gender
DV=DBP; Gender
Full
0.086 -31437.010 2.90E+53 1.000 0.045 -17280.930
1.13E+49
<.001
Reduced 0.084 -31683.200
0.037 -17506.830
DV=SBP; SES
DV=DBP; SES
Full
0.089 -31554.980 1.41E+25 0.019 0.042 -17249.850 8.23805E+60 0.073
Reduced 0.082 -31670.800
0.037 -17530.380
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008
Model

R2

The relationship between Acting with Awareness and SBP did not differ across
demographics. Based on the R2 difference p-values, the relationship between Acting with
Awareness and DBP seemed to differ as a function of both age and gender, though the
BIC and BF indicated the reduced models as more efficient, shown in Table 6.
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Table 7
Results of the Clinic BP Model Comparisons For Nonjudging (n=296)
Model

R2

BIC
BF
P
R2
BIC
BF
P
DV=SBP; Race
DV=DBP; Race
Full
0.110 -30734.150 6.14E-11 <.001 0.052 -17078.820
9.35E+48
0.043
Reduced 0.107 -30687.120
0.048 -17304.340
DV=SBP; Age
DV=DBP; Age
Full
0.107 -30607.620 1.17E-42 1.000 0.050 -17295.930
3.95E+09
0.001
Reduced 0.105 -30414.520
0.048 -17340.130
DV=SBP; Gender
DV=DBP; Gender
Full
0.107 -30578.690 5.08E+35 0.258 0.050 -17268.040
5.33E+09
1.000
Reduced 0.105 -30743.120
0.050 -17312.840
DV=SBP; SES
DV=DBP; SES
Full
0.110 -30456.000 9.34E+55 0.054 0.051 -17189.900 1.69192E-16 0.057
Reduced 0.106 -30713.750
0.049 -17117.270
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between Nonjudging and BP
appeared to differ as a function of race across SBP and age across DBP, and the BIC and
BF concurrently slightly favored the full model in race across SBP, but not in age across
DBP, shown in Table 7. The relationship between Nonreactivity and BP, or Decentering
and BP, did not differ across demographics.
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Table 8
Results of the Ambulatory BP Model Comparisons For Observing (n=94)
Model

R2

BIC

BF

P

R2

BIC

BF

P

DV=SBP; Race
DV=DBP; Race
Full
0.034 -11222.770
5.63E-13
1.000 0.102 -7792.974
1.55E-38
1.000
Reduced 0.035 -11166.360
0.107 -7618.861
DV=SBP; Age
DV=DBP; Age
Full
0.036 -11578.070
2.26E+18 1.000 0.112 -7837.483
2.61E-01
1.000
Reduced 0.034 -11662.590
0.099 -7834.794
DV=SBP; Gender
DV=DBP; Gender
Full
0.055 -11385.810
5.84E-51
<.001 0.118 -7687.497
5.32E+37
<.001
Reduced 0.035 -11154.470
0.094 -7861.230
DV=SBP; SES
DV=DBP; SES
Full
0.037 -11725.370
3.14E-127 1.000 0.100 -7924.594 2.4355E-74 0.294
Reduced 0.034 -11142.800
0.098 -7585.592
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

In ambulatory BP, the relationship between the Observing facet and BP appeared
to differ as a function of gender across both SBP and DBP based on the R2 difference pvalues, and the BIC and BF concurrently slightly favored the full model in SBP but not
DBP, shown in Table 8.
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Table 9
Results of the Ambulatory BP Model Comparisons For Describing (n=94)
Model
R2
BIC
BF
P
R2
BIC
BF
P
DV=SBP; Race
DV=DBP; Race
Full
0.043 -11523.620
2.47E-88
1.000 0.092 -7781.495 2.34E+25 0.003
Reduced 0.037 -11120.180
0.091 -7898.321
DV=SBP; Age
DV=DBP; Age
Full
0.035 -11696.420 1.51E-102 1.000 0.126 -7529.617 6.02E+77 <.001
Reduced 0.036 -11227.510
0.087 -7887.805
DV=SBP; Gender
DV=DBP; Gender
Full
0.085 -11144.210
8.16E-23
0.001 0.093 -7974.978 1.41E-84 0.403
Reduced 0.034 -11042.490
0.092 -7588.824
DV=SBP; SES
DV=DBP; SES
Full
0.042 -11038.580
3.34E+25 1.000 0.126 -7673.483 39.92609 0.006
Reduced 0.037 -11156.120
0.086 -7680.857
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP
did NOT differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between the Describing facet
and SBP differed again as a function of gender, and the BIC and BF concurrently slightly
favored the full model, while in DBP, it differed as a function of race, age, and SES,
though the BIC and BF favored the reduced models, shown in Table 9.
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Table 10
Results of the Ambulatory BP Model Comparisons For Acting with Awareness (n=94)
Model

R2

BIC
BF
P
R2
BIC
BF
P
DV=SBP; Race
DV=DBP; Race
Full
0.041 -11227.630
7.45E-44
0.003 0.111 -7802.959
1.06E-08
0.003
Reduced 0.037 -11029.020
0.105 -7766.229
DV=SBP; Age
DV=DBP; Age
Full
0.037 -11068.170
9.90E+133 1.000 0.107 -7716.173
1.17E+13
0.256
Reduced 0.037 -11685.240
0.106 -7776.348
DV=SBP; Gender
DV=DBP; Gender
Full
0.042 -11015.400
6.82E+24
1.000 0.104 -7641.384
2.55E+18
1.000
Reduced 0.037 -11129.770
0.102 -7726.147
DV=SBP; SES
DV=DBP; SES
Full
0.046 -11722.160
2.90E-54
0.001 0.134 -7446.191
1.47632E+67
0.001
Reduced 0.036 -11475.610
0.101 -7755.516
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did NOT
differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between Acting with
Awareness and BP differed as a function of Race and SES across both SBP and DBP, and
the BIC and BF concurrently slightly favored the full models in each of these potential
demographic differences except for in SES across DBP, shown in Table 10.
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Table 11
Results of the Ambulatory BP Model Comparisons For Nonjudging (n=94)
Model

R2

Full
Reduced

0.063
0.034

Full
Reduced

0.035
0.033

Full
Reduced

0.070
0.034

BIC
BF
DV=SBP; Race
-10742.120
2.70E+67
-11052.650
DV=SBP; Age
-11717.100
8.82E-117
-11182.650
DV=SBP; Gender
-10833.320
1.13E+214
-11819.070

P

R2

<.001

0.105
0.096

1.000

0.105
0.095

<.001

0.096
0.090

DV=SBP; SES
Full
Reduced

0.093
0.035

-11084.280
-11389.260

1.68E+66

BIC
BF
DV=DBP; Race
-7698.167
3.06E+25
-7815.535
DV=DBP; Age
-7714.419
1.98E+44
-7918.408
DV=DBP; Gender
-7907.680
8.45E-13
-7852.081

P
1.000

1.000

0.014

DV=DBP; SES
<.001

0.149
0.093

-7146.706
-7879.694

1.4664E+159

<.001

Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between Nonjudging and BP
differed as a function of SES across both SBP and DBP, and additionally differed across
race and gender in only SBP, while the BIC favored the reduced models, shown in Table
11. The relationship between Nonreactivity and BP did not differ as a function of
demographics.
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Table 12
Results of the Ambulatory BP Model Comparisons For Decentering (n=94)
Model

R2

BIC
BF
P
R2
BIC
BF
P
DV=SBP; Race
DV=DBP; Race
Full
0.043 -10924.980
3.31E+08
0.003 0.108 -7739.156
6.38E+08
1.000
Reduced 0.042 -10964.220
0.097 -7779.703
DV=SBP; Age
DV=DBP; Age
Full
0.042 -11738.690
1.89E-123
0.262 0.149 -7398.757
1.25E+136
1.000
Reduced 0.041 -11173.530
0.099 -8025.509
DV=SBP; Gender
DV=DBP; Gender
Full
0.045 -11061.020
1.16E+104 0.010 0.103 -7664.356
4.30E+34
0.129
Reduced 0.042 -11540.250
0.096 -7823.848
DV=SBP; SES
DV=DBP; SES
Full
0.049 -11091.560
2.00E+69
0.021 0.109 -7829.468
3.0365E-06 0.328
Reduced 0.041 -11410.700
0.101 -7804.058
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

The relationship between Decentering and SBP did not differ as a function of
demographics, and although earlier analyses indicated that the relationship between
Decentering and DBP may differ as a function of demographics, no individual
demographic interactions significantly explained more variance in BP when comparing
the full and reduced model R2. Furthermore, the BIC and BF favored the reduced models
in all cases but SES, shown in Table 12.
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Table 13
Results of the BP Reactivity Model Comparisons For Observing (n=152)
Model

R2

Full
Reduced

0.063
0.062

Full
Reduced

0.063
0.062

Full
Reduced

0.064
0.062

Full
Reduced

0.063
0.061

BIC
BF
DV=SBP; Race
-11448.470 1.99E+19
-11537.340
DV=SBP; Age
-11534.180 1.46E+13
-11594.810
DV=SBP; Gender
-11526.460 3.88E+14
-11593.650
DV=SBP; SES
-11549.850 4.04E+40
-11736.850

P

R2

0.160

0.022
0.017

1.000

0.022
0.015

0.004

0.020
0.016

0.200

0.027
0.015

BIC
BF
DV=DBP; Race
-5439.088
7.04E+16
-5516.675
DV=DBP; Age
-5445.172
4.93E+17
-5526.653
DV=DBP; Gender
-5453.444
1.52E+24
-5564.809
DV=DBP; SES
-5426.326
1.41942E+18
-5509.919

P
<.001

<.001

<.001

0.086

Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

In BP reactivity to stress, the relationship between the Observing facet and SBP
reactivity did not differ across demographics, while the relationship between Observing
and DBP reactivity appeared to differ as a function of race, age, and gender based on the
R2 difference p-values, though the BIC and BF still favored the reduced models, shown in
Table 13.

40

Table 14
Results of the BP Reactivity Model Comparisons For Describing (n=152)
Model

R2

Full
Reduced

0.063
0.062

Full
Reduced

0.064
0.062

Full
Reduced

0.071
0.062

BIC
BF
DV=SBP; Race
-11494.960
5.99E+20
-11590.640
DV=SBP; Age
-11516.800
1.62E+09
-11559.210
DV=SBP; Gender
-11424.960
1.73E+39
-11605.660
DV=SBP; SES

P

R2

1.000

0.022
0.015

0.032

0.028
0.017

0.016

0.017
0.017

BIC
BF
DV=DBP; Race
-5545.621
4.66E-07
-5516.461
DV=DBP; Age
-5390.455
1.02E+22
-5491.810
DV=DBP; Gender
-5479.768
6.62E+13
-5543.416
DV=DBP; SES

P
0.002

1.000

0.425

Full
0.066 -11434.800
5.25E+26 0.152 0.023 -5469.174
5.73089E-07
0.267
Reduced 0.063 -11557.850
0.017 -5440.429
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between Describing and SBP
reactivity appeared to differ as a function of race, and the BIC and BF concurrently
slightly favored the full model, shown in Table 14.
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Table 15
Results of the BP Reactivity Model Comparisons For Acting with Awareness (n=152)
Model

R2

BIC

BF

P

R2

DV=SBP; Race
Full

0.080

-11422.060

Reduced

0.079

-11451.900

3.01E+06

0.092

-11109.210

Reduced

0.081

-11233.370

9.16E+26

0.005

0.034

-5421.057

0.015

-5492.221

0.094

-10953.920

Reduced

0.080

-11250.890

3.06E+64

<.001

0.015

-5425.685

0.015

-5437.342

0.095

-11099.750

Reduced

0.081

-11279.890

1.31E+39

2.84E+15

1.000

3.40E+02

1.000

DV=DBP; Gender
<.001

0.014

-5485.268

0.014

-5518.477

DV=SBP; SES
Full

P

DV=DBP; Age

DV=SBP; Gender
Full

BF

DV=DBP; Race

DV=SBP; Age
Full

BIC

1.63E+07

0.542

DV=DBP; SES
0.011

0.042

-5229.218

0.015

-5494.663

4.37151E+57

0.029

Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between Acting with
Awareness and BP reactivity appeared to differ as a function of race, age, and gender
across SBP, though the BIC and BF still favored the reduced models. Although earlier
analyses indicated that the relationship between Acting with Awareness and DBP may
differ as a function of demographics, no individual demographic interactions significantly
explained more variance in BP when comparing the full and reduced model R2, shown in
Table 15.
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Table 16
Results of the BP Reactivity Model Comparisons For Nonjudging (n=152)
Model

R2

BIC
BF
P
R2
BIC
BF
P
DV=SBP; Race
DV=DBP; Race
Full
0.113 -10789.620
3.36E+85 <.001 0.084 -5215.008
6.63E-08
<.001
Reduced 0.092 -11183.480
0.056 -5181.950
DV=SBP; Age
DV=DBP; Age
Full
0.094 -11116.120
2.02E+37 0.047 0.068 -5163.083
1.19E+03
<.001
Reduced 0.092 -11287.920
0.062 -5177.250
DV=SBP; Gender
DV=DBP; Gender
Full
0.101 -11043.310
1.63E+22 <.001 0.062 -5221.836
1.48E+02
0.009
Reduced 0.094 -11145.600
0.056 -5231.824
DV=SBP; SES
DV=DBP; SES
Full
0.107 -10952.480
2.78E+43 <.001 0.098 -5056.884
1.08073E+21
<.001
Reduced 0.091 -11152.550
0.058 -5153.748
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did NOT
differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between Nonjudging and BP
reactivity appeared to differ as a function of race and SES across both SBP and DBP,
gender in only SBP, and age in only DBP, though the BIC and BF favored the full model
for only race across DBP, and favored the reduced model for all other comparisons,
shown in Table 16.
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Table 17

Results of the BP Reactivity Model Comparisons For Nonreactivity (n=152)
BIC
BF
P
R2
BIC
BF
P
Model
R2
DV=DBP; Race
DV=SBP; Race
1.96E+12 0.019 0.018 -5477.270
1.10E-10
1.000
Full
0.081 -11353.120
0.017 -5431.408
Reduced 0.075 -11409.720
DV=DBP; Age
DV=SBP; Age
1.19E+14 0.069 0.018 -5505.541
2.46E-04
0.319
Full
0.080 -11373.640
0.016 -5488.922
Reduced 0.075 -11438.450
DV=DBP; Gender
DV=SBP; Gender
5.78E-23 <.001 0.016 -5450.295
1.46E+05
<.001
Full
0.080 -11402.270
0.018 -5474.076
Reduced 0.078 -11299.860
DV=DBP; SES
DV=SBP; SES
9.06E-27 1.000 0.016 -5445.221
6572099809
0.164
Full
0.077 -11415.460
0.015 -5490.433
Reduced 0.076 -11295.530
Note: Blackened sections denote that the relationship between the trait mindfulness facet and
BP did NOT differ across demographics. Bold denotes significance, α=.008

Based on the R2 difference p-values, the relationship between Nonreactivity and
SBP reactivity appeared to differ as a function of gender, and the BIC and BF
concurrently favored the full model, shown in Table 17. The relationship between
Nonreactivity and DBP reactivity did not differ across demographics.
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Table 18
Results of the BP Reactivity Model Comparisons For Decentering (n=152)
Model

R2

Full
Reduced

0.077
0.080

Full
Reduced

0.088
0.080

BIC
BF
DV=SBP; Race
-11339.720 1.56E+06
-11368.250
DV=SBP; Age
-11236.650 2.09E+31
-11380.890

P

R2

1.000

0.021
0.019

<.001

0.020
0.019

DV=SBP; Gender
Full
Reduced

BIC
BF
DV=DBP; Race
-5484.373
2.98E-03
-5472.744
DV=DBP; Age
-5447.246
2.85E+05
-5472.367

P
0.002

0.387

DV=DBP; Gender

0.089
0.079

-11195.420 2.61E+22 0.011 0.023 -5439.144
1.56E-11
1.000
-11298.660
0.021 -5389.382
DV=SBP; SES
DV=DBP; SES
Full
0.084 -11340.430
6.48E-06 0.153 0.022 -5402.224
2.96287E+12 0.641
Reduced 0.078 -11316.540
0.019 -5459.659
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did
NOT differ across demographics. Bold denotes significance, α=.008

Based on R2 difference p-values, the relationship between Decentering and SBP
reactivity seemed to differ as a function of age, though the BIC and BF still favored the
reduced model, shown in Table 18. The relationship between Nonreactivity and DBP
reactivity did not differ across demographics.
Aim 2. Does MBSR training lower clinic BP, the AHA ‘gold standard’ BP
measurement (Chobanian et al., 2003), and does it do so across different subgroups (age,
gender, race, SES) and different initial levels of trait mindfulness?
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ΔSBP
ΔDBP
ΔSBP
ΔDBP
ΔSBP
ΔDBP
ΔSBP
ΔDBP
ΔSBP
ΔDBP
ΔSBP
ΔDBP

Effect Sizes
All MBSR Participants (n=44)
0.00
-0.18
Black Participants (n=11)
0.82
0.14
White Participants (n=31)
-0.18
-0.35
Younger Age Participants (n=11)
0.65
0.01
Middle Age Participants (n=21)
-0.32
-0.32
Older Age Participants (n=13)
-0.06
-0.20

CI
-.33, .34
-.46, .09
.03, 1.7
-.46, .82
-.58, .22
-.67, -.04
.05, 1.34
-.45, .47
-.84, .17
-.74, .08
-.74, .61
-.93, .49

Effect Sizes
Male Participants (n=24)
-0.11
-0.07
Female Participants (n=23)
0.10
-0.35
Lower SES Participants (n=24)
0.24
-0.25
Higher SES Participants (n=17)
-0.30
-0.08
Lower Initial Trait Mindfulness (n=16)
-0.18
-0.16
Higher Initial Trait Mindfulness (n=29)
0.21
-0.19

Figure 2. Heatmap of Hedges’ G effect size (ES) following the intervention. Brighter
green indicates decreases in blood pressure (BP) following MBSR training, whereas
brighter red indicates increases in BP.

As the group sample sizes are particularly small, the following results should be
viewed as preliminary and interpreted with caution. Among all participants randomized
to MBSR training (n=44), change in SBP following MBSR training was negligible (.26
mmHg, [-2.96, 3.02]; g = .00, [-.33, .34]). Change in DBP was in the direction
anticipated but did not reach designated clinical relevance (-1.27 mmHg, [-3.19, .65]; g =
-.18, [-.45, .09]). Among White participants (n=31), there was no effect on SBP, as the CI
of the ES contained zero (-1.7 mmHg, [-5.63, 2.16]; g = -.179, [-.58, .215]), while the
decrease in DBP reached designated clinically relevant ES (-2.38 mmHg, [-4.44, -.316]; g
= -.35, [-.67, -.04]). Among Black participants (n=11), SBP increased, against our
prediction (5.02 mmHg, [.25, 9.81]; g = .82, [.034, 1.7]), though there was no effect in
DBP, as the CI of the ES contained zero (1.45 mmHg, [-4.26, 7.16]; g = .14, [-.46, .83]).
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The differences in intervention ES between Black and White race participants reached
significance in SBP but not DBP, as the CIs of each group’s ES overlapped.
In younger age participants (n=11), SBP increased, against our prediction (6.12
mmHg, [.548, 11.7]; g = .65, [.05, 1.34]), while change in DBP was negligible (.09
mmHg, [-4.98, 5.16]; g = .00, [-.45, .47]). In middle age participants (n=21), there was
no effect in either SBP (-2.83 mmHg, [-7.27, 1.26]; g = -.32, [-.84, .17]) or DBP, (-2.1
mmHg, [-4.78, .59]; g = -.32, [-.74, .08]), as the CI of the ES contained zero. Similar null
results occurred in older age participants (n=13) across SBP (-.53 mmHg, [-6.55, 5.5]; g
= -.06, [-.738, .609]), and DBP (-1.09 mmHg, [-5, 2.83]; g = -.2, [-.33, .34]). The
differences in intervention ES between participants of younger, middle, and older age did
not reach significance.
Among male participants (n=22), there was no effect in either SBP (-.95 mmHg,
[-5.44, 3.53]; g = -.11, [-.63, .4]) or DBP (-.59 mmHg, [-3.6, 2.42]; g = .07, [-.41, .27]).
Similar null effects occurred among female participants (n=23), with no effect in either
SBP (.96 mmHg, [-3.34, 5.27]; g = .1, [-.34, .55]), or DBP (-1.92 mmHg, [-4.55, .71]; g
= -.354, [-.852, .124]), as the CIs of the ESs contained zero. Differences in ES across
male and female gender participants did not reach significance.
In lower SES participants (n=24, household income < $75,000) there was no
effect in SBP (2.27 mmHg, [-2.2, 6.74]; g = .239, [-.22, .717]), or DBP (-1.92 mmHg, [4.8, .95]; g = -.25, [-.63, .118]), as the CIs of the ESs contained zero. In higher SES
participants (n=17, household income > $75,000), there was no effect of SBP (-2.67
mmHg, [-7.35, 2.03]; g = -.297, [-.83, .21]) or DBP (-.51 mmHg, [-3.57, 2.55]; g = -.08,
[-.56, .387]), as the CIs of the ESs contained zero. Differences in intervention ES across
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lower and higher SES did not reach significance. Among participants with lower initial
trait mindfulness (n=16, trait mindfulness at or below meditation-naive population mean),
there were no effects of SBP (-1.95 mmHg, [-7.26, 3.34]; g = -.18, [-.67, .29]), or DBP (1.4 mmHg, [-5.28, 2.49]; g = -.16, [-.62, .28]), as the CIs of the ESs contained zero.
Similar null results were found among participants with higher initial trait
mindfulness (n=29, trait mindfulness above meditation-naive population mean) in SBP
(1.12 mmHg, [-2.68, 4.92]; g = .211, [-.27, .738]) and DBP (-1.2 mmHg, [-3.49, 1.08]; g
= -.19, [-.54, .162]). Differences in intervention ES in participants with lower and higher
initial levels of trait mindfulness did not reach significance.
Aim 3. Are changes in trait mindfulness facets and BP following MBSR training
correlated, and do these correlations occur across different subgroups (age, gender, race,
SES) and different initial levels of trait mindfulness?
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ΔActing with
ΔNonjudging ΔNonreactivity ΔDecentering
Awareness
All MBSR Participants (n=44)
-0.28
0.02
0.05
0.01
-0.08
-0.17
0.08
0.22
0.17
0.14
Black Participants (n=11)
-0.10
0.31
0.39
0.34
0.37
0.12
0.40
0.61
0.53
0.54
White Participants (n=31)
-0.44
-0.03
0.03
0.03
-0.09
-0.45
-0.02
0.16
0.07
-0.02
Younger Age Participants (n=11)
-0.15
0.34
0.20
0.09
-0.09
0.35
0.54
0.39
0.49
0.46
Middle Age Participants (n=21)
-0.30
0.09
0.13
-0.17
-0.23
-0.34
-0.11
0.31
-0.09
-0.12
Older Age Participants (n=13)
-0.39
-0.30
-0.35
0.06
-0.08
-0.47
-0.34
-0.16
0.14
0.11
Male Participants (n=22)
-0.34
-0.02
0.27
0.01
-0.17
-0.15
0.19
0.38
0.27
0.17
Female Participants (n=23)
-0.19
0.00
-0.20
0.01
0.05
-0.23
0.00
0.06
0.08
0.09
Lower SES Participants (n=23)
-0.33
-0.20
0.02
0.04
-0.21
-0.58
-0.10
0.36
0.06
0.00
Higher SES Participants (n=17)
-0.26
-0.01
0.04
-0.03
0.20
0.01
0.00
0.01
0.11
0.19
Lower Initial Trait Mindfulness (n=16)
-0.24
0.31
0.26
0.10
0.04
0.18
0.26
0.29
0.37
0.22
Higher Initial Trait Mindfulness (n=28)
-0.28
-0.15
-0.04
0.05
-0.11
-0.54
-0.10
0.16
0.02
0.07
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ΔDBP
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0.06

ΔSBP
ΔDBP
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ΔSBP
ΔDBP

-0.01
-0.14

ΔSBP
ΔDBP

-0.62
0.13

ΔSBP
ΔDBP

-0.12
-0.08

ΔSBP
ΔDBP

0.13
0.06

ΔSBP
ΔDBP

-0.15
0.05

ΔSBP
ΔDBP

0.03
0.07

ΔSBP
ΔDBP

-0.01
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ΔSBP
ΔDBP

0.13
0.01

ΔSBP
ΔDBP

0.03
-0.12

ΔSBP
ΔDBP

-0.01
0.14

Figure 3. Heatmap of correlations between change (increases) in trait mindfulness and
change in BP following the intervention. Green indicates that as the trait mindfulness
facet increased, BP decreased, while red indicates that as the facet increased, so did BP.
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To ease interpretation, most participants (82%) had increased trait mindfulness
following the intervention (x̄ increase across all participants = 14.86 points, or 13%).
Furthermore, each demographic included in this analysis showed increases in mean trait
mindfulness. Overall, correlations with change values are likely operating as an increase
in mindfulness correlated with an increase or decrease in BP. Still, as the group sample
sizes are particularly small, increasing the possibility of apparent findings being noise,
these results should be viewed as pilot data to avoid over-interpretation.
Among all MBSR training group completers (n=44), no correlations between
change in trait mindfulness facets and change in BP reached clinically relevant ESs.
Among Black participants (n=11), correlations of change in trait mindfulness facets and
change in BP were null, as the CIs of the correlation ES contained zero, as shown in
Appendix E. Among White participants (n=31), correlations reached clinically relevant,
medium ES in the predicted direction between Describing, SBP (r = -.44, [-.69, -.1]) and
DBP (r = -.45, [-.69, -.1]), as shown in Figure 3. Correlational differences between
change in trait mindfulness and change in BP did not reach significance across race, as
the CIs of each group’s ES overlapped.
In younger age participants (n=11), correlations reached clinically relevant, large
ES in the predicted direction in Observing and SBP (r = -.62, [-.89, -.03]), but not DBP,
as shown in Figure 3. All other correlations between change in trait mindfulness facets
and change in BP were null, as the CIs of the correlation ESs contained zero, as shown in
Appendix E. In middle age participants (n=21), all correlations between change in trait
mindfulness and change in BP were null, as the CIs of the correlation ESs contained zero.
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Similar null results occurred in older age participants (n=13), as shown in Appendix E.
Correlational differences between change in trait mindfulness and change in BP did not
reach significance across age.
Among both male (n=22) and female (n=23) participants, all correlations between
change in trait mindfulness and change in BP were null, as the confidence of the
correlation ESs contained zero. Similar null results occurred across both lower SES
participants (n=23, household income < $75,000), and higher SES participants (n=17,
household income > $75,000). Correlational differences between change in trait
mindfulness and change in BP did not reach significance across SES. Again, among both
participants with lower initial trait mindfulness (n=16) and participants with higher initial
trait mindfulness (n=28), all correlations between change in trait mindfulness and change
in BP were null, as shown in Appendix E. Correlational differences between change in
trait mindfulness and change in BP did not reach significance across initial level of trait
mindfulness.
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Chapter Four

Discussion
The current study aimed to answer three questions about mindfulness, diversity,
and health. First, at baseline, does higher trait mindfulness relate to lower BP after
controlling for known covariates of BP, and does this relationship differ as a function of
demographics (race, age, gender and SES)? No trait mindfulness facets related to BP
after controlling for covariates of BP. Still, the combination of small but significant
improvements to R2, alongside the BIC and BF metrics favoring some models accounting
for demographic interactions over models without said interactions, implies that the
relationship between some trait mindfulness facets and BP may differ as a function of
some demographics, potentially driving the appearance of null effects when analyzing the
sample in its entirety. These significant demographic differences most often occurred
across race and gender, and in the relationship between Acting with Awareness and
ambulatory BP, although they appeared across every trait mindfulness facet except
Decentering, and in each form of BP. The current findings support a null relationship
between trait mindfulness and BP, that may vary in strength across demographics,
particularly race and gender.
Second, does MBSR training lower clinic BP, and does it do so across different
subgroups and different initial levels of trait mindfulness? Looking at the entire sample,
MBSR training did not lower clinic BP at clinically relevant levels. However, the current
findings indicate that MBSR training lowers clinic BP at clinically relevant ES in White
but not Black people, for whom MBSR training increased BP at clinically relevant ES.
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While the SBP differences between White and Black participants reached significance,
no other differences across demographic groups reached significance, likely due to small
sample size. Regardless, these differences across race may have caused the appearance of
null effects when the sample was viewed in its entirety.
Third, are changes in trait mindfulness facets and BP following MBSR training
correlated, and do these correlations occur across different subgroups and different initial
levels of trait mindfulness? In the entire sample, change in specific trait mindfulness
facets did not appear to correlate with change in BP at clinically relevant ES. This is most
likely due null effects of MBSR training on BP across most demographic groups in the
current study. However, in White participants, increased Describing correlated with
decreased BP, and in younger age participants, increased Observing correlated with
decreased SBP specifically. It is possible that the correlation in younger age participants
is noise, as BP did not significantly change in younger age participants following MBSR
training. Other demographic subgroups, namely gender, SES, and the different initial
levels of trait mindfulness, similarly displayed null results due to the correlation ES CIs
containing zero. And, differences across demographic subgroups in all the correlations
between change in trait mindfulness and change in BP did not reach clinical significance,
likely due to small sample size.
Overall, these findings tentatively imply that for most demographic groups, we
cannot assume changes in trait mindfulness drive changes in health resulting from MBSR
training, or that for some demographic groups, MBSR training will improve health at all.
The current literature on mindfulness, whether as a state, trait, or training, de-emphasizes
potential demographic differences in the effects of mindfulness on health and well-being
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(Chin, Anyanso & Greeson, 2019). While theoretically MBSR training emphasizes skills
inherent to all people, the assumption that beneficial health-related effects of mindfulness
are consistent across demographics does not account for significant demographic health
disparities, including differing rates of disease at a purely biological level, different levels
of access to healthcare and to other resources necessary for health and well-being, as well
as disparities in stress, which likely changes in type and intensity in relation to
demographic subgroup, for example. The current preliminary findings emphasize this
disparity, illustrating that trait mindfulness might not relate to BP equally across
demographics, and moreover that MBSR training as an intervention may be effective in
improving cardiovascular health for one specific racial demographic--people who are
White—but could conceivably increase BP in other racial demographics, particularly
people who are Black. In our sample, eight of the eleven Black participants who
completed MBSR experienced elevated BP, while the remaining three decreased.
Although these findings are preliminary, they tentatively imply that the relationships
between mindfulness and other health domains may similarly vary. Future mindfulness
studies should aim to improve diversity in samples to further explore potential
demographic differences in the relationship between mindfulness and health, rather than
assuming beneficial effects generalize across different populations.
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ΔDescribing

ΔSBP
ΔDBP

-0.05
0.06

-0.28
-0.17

All Participants (n=44)
0.02
0.05
0.08
0.22

0.01
0.17

-0.08
0.14

-.34, .251
-.244, .347

-.529, .014
-.443, 134

-.273, .313
-.44, .131

-.249, .336
-.082, .479

-.279, .307
-.129, .442

-.364, .218
-.16, .416

ΔSBP
ΔDBP

0.17
0.57

-0.10
0.12

Black Participants (n=11)
0.31
0.39
0.40
0.61

0.34
0.53

0.37
0.54

-.478, .698
-.043, .872

-.66, .531
-.518, .67

-.354, .768
-.26, .807

-.271, .803
.015, .885

-.276, .801
-.107, .855

-.297, .792
-.082, .862

ΔSBP
ΔDBP

-0.01
-0.14

-0.44
-0.45

White Participants (n=31)
-0.03
0.03
-0.02
0.16

0.03
0.07

-0.09
-0.02

-.364, .355
-.473, .234

-.688, -.09
-.696, -.106

-.388, .331
-.377, .342

-.33, .389
-.21, .493

-.336, 383
-.295, .421

-.436, .279
-.373, .347

ΔSBP
ΔDBP

-0.62
0.13

Younger Age Participants (n=11)
-0.15
0.34
0.20
0.35
0.54
0.39

0.09
0.49

-0.09
0.46

-.889, -.034
-.51, .676

-.686, .496
-.314, .785

-.325, .781
-.082, .862

-.451, .716
-.277, .8

-.54, .653
-.158, .841

-.656, .536
-.191, .831

ΔSBP
ΔDBP

-0.12
-0.08

Middle Age Participants (n=21)
-0.30
0.09
0.13
-0.34
-0.11
0.31

-0.17
-0.09

-0.23
-0.12

-.523, .329
-.497, .36

-.645, .155
-.673, .106

-.356, .501
-.52, .334

-.322, .529
-.141, .653

-.56, .282
-.505, .351

-.601, .223
-.523, .33

ΔSBP
ΔDBP

0.13
0.06

Older Age Participants (n=13)
-0.39
-0.30
-0.35
-0.47
-0.34
-0.16

0.06
0.14

-0.08
0.11

-.456, .633
-.507, .592

-.775, .202
-.809, .113

-.731, .298
-.75, .258

-.755, .249
-.655, .426

-.507, .591
-.442, .643

-.604, .491
-.466, .625

ΔSBP
ΔDBP

-0.15
0.05

-0.34
-0.15

Male Participants (n=22)
-0.02
0.27
0.19
0.38

0.01
0.27

-0.17
0.17

-.536, .29
-.382, .459

-.667, .093
-.533, .294

-.44, .402
-.255, .563

-.167, .622
-.053, .689

-.416, .426
-.172, .62

-.553, .269
-.274, .549

ΔSBP
ΔDBP

0.03
0.07

-0.19
-0.23

Female Participants (n=23)
0.00
-0.20
0.00
0.06

0.01
0.08

0.05
0.09

-.389, .434
-.347, .472

-.556, .244
-.588, .198

-.41, .413
-.413, .41

-.566, .299
-.457, .364

-.402, .422
-.343, 476

-.366, .456
-.332, .485

ΔSBP
ΔDBP

-0.01
0.17

Lower SES Participants (n=23)
-0.33
-0.20
0.02
-0.58
-0.10
0.36

0.04
0.06

-0.21
0.00

-.424, .399
-.262, .542

-.655, .09
-.799, -.217

-.563, .234
-.49, .327

-.395, .428
-.06, .673

-.379, .444
-.362, .46

-.571, .222
-.416, .408

ΔSBP
ΔDBP

0.13
0.01

Higher SES Participants (n=17)
-0.26
-0.01
0.04
0.01
0.00
0.01

-0.03
0.11

0.20
0.19

-.371, .576
-.473, .487

-.655, .256
-.47, .49

-.486, .474
-.479, .482

-.466, .513
-.473, .487

-.504, .456
-.388, .563

-.311 to .62
-.321, .613

ΔSBP
ΔDBP

0.03
-0.12

Lower Initial Trait Mindfulness (n=16)
-0.24
0.31
0.26
0.18
0.26
0.29

0.10
0.37

0.04
0.22

-.471, .519
-.581, .399

-.654, .295
-.342, .622

-.216, .7
-.271, .668

-.275, .66
-.238, .688

-.413, .569
-.151, .732

-.463, 526
-.317, .639

ΔSBP
ΔDBP

-0.01
0.14

Higher Initial Trait Mindfulness (n=28)
-0.28
-0.15
-0.04
-0.54
-0.10
0.16

0.05
0.02

-0.11
0.07

-.379, .367
-.245, .487

-.589, .107
-.757, -.204

-.497, .233
-.457, .281

-.41, .334
-.227, .502

-.325, .418
-.352, .393

-.46, .278
-.313, .43
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